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Background—The PR interval (PR) as measured by the resting, standard 12-lead
electrocardiogram (ECG) reflects the duration of atrial/atrioventricular nodal depolarization.
Substantial evidence exists for a genetic contribution to PR, including genome-wide association
studies that have identified common genetic variants at nine loci influencing PR in populations of
European and Asian descent. However, few studies have examined loci associated with PR in
African Americans.
Methods and Results—We present results from the largest genome-wide association study to
date of PR in 13,415 adults of African descent from ten cohorts. We tested for association between
PR (ms) and approximately 2.8 million genotyped and imputed single nucleotide polymorphisms.
Imputation was performed using HapMap 2 YRI and CEU panels. Study-specific results, adjusted
for global ancestry and clinical correlates of PR, were meta-analyzed using the inverse variance
method. Variation in genome-wide test statistic distributions was noted within studies (lambda
range: 0.9–1.1), although not after genomic control correction was applied to the overall meta-
analysis (lambda: 1.008). In addition to generalizing previously reported associations with MEIS1,
SCN5A, ARHGAP24, CAV1, and TBX5 to African American populations at the genome-wide
significance level (P<5.0×10−8), we also identified a novel locus: ITGA9, located in a region
previously implicated in SCN5A expression. The 3p21 region harboring SCN5A also contained
two additional independent secondary signals influencing PR (P<5.0×10−8).
Conclusions—This study demonstrates the ability to map novel loci in African Americans as
well as the generalizability of loci associated with PR across populations of African, European and
Asian descent.
Keywords
electrocardiography; epidemiology; GWAS; single nucleotide polymorphism genetics; PR interval
Introduction
The PR interval (PR) is an electrocardiographic measurement of atrial conduction spanning
the onset of sinus depolarization through the atrioventricular node. PR is a predictor of
incident atrial fibrillation,1 a common cardiac arrhythmia,2 and a potent risk factor for
pacemaker implantation, heart failure, stroke, and all-cause mortality.1, 3 Substantial
evidence exists for a genetic contribution to PR. Family-based studies have estimated the
heritability of PR at approximately 34%4, 5 and rare sodium channel mutations associated
with atrial cardiac conduction defects have been characterized.6, 7 Recent genome-wide
association (GWA) studies performed in populations of European and Asian descent have
identified common polymorphisms at nine loci that are associated with variation in
PR.5, 8–11 For example, ARHGAP24, CAV1, SCN10A, and TBX5 have been reported in at
least two PR GWA studies.
To date, the majority of GWA studies examining PR were performed in populations of
European or Asian descent. The exception is a report by Smith and colleagues (2011),12
which generalized four previously described PR loci identified in European and Asian
populations (SCN5A, SCN10A, MEIS1, and TBX5) to 6,247 African American participants
from four cohorts. However, Smith and colleagues neither detected novel associations nor
identified genome-wide significant associations with several previously replicated loci,
including ARHGAP24, CAV1 and WNT11.9, 10 It is therefore unclear whether these loci are
relevant in African Americans. Additionally, the increased genetic diversity in populations
of African descent provides opportunities for the identification of novel variants influencing
PR. Epidemiologic studies have also reported that PR is longer in individuals of African
compared to European ancestry,13, 14 which provides additional motivation for GWA studies
of PR in populations of African descent.
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To further characterize genetic determinants of PR in populations of African descent, we
extended the earlier efforts of Smith et al.12 by including GWA study data from six
additional African American cohorts (7,168 additional participants). These results were
meta-analyzed with those previously reported by Smith et al. to provide the largest GWA
study of PR to date in populations of African ancestry.
Results
We performed a GWA analysis of PR in 13,415 adults of African descent from ten cohorts,
including three studies from the Continental Origins and Genetic Epidemiology Network
(COGENT)15 and four studies from the Candidate-gene Association Resource (CARe)
consortia.16 Four of the ten studies were included in the earlier study by Smith et al.:12 the
Atherosclerosis Risk in Communities (ARIC) Study, the Cleveland Family Study (CFS), the
Jackson Heart Study (JHS), and the Multi-Ethnic Study of Atherosclerosis (MESA).
Variation in study size was noted across cohorts (range: 191 – 4,149 participants) and the
largest contributing study was composed entirely of females (Table 1). Across studies,
participants were predominantly female (72%), middle-aged (overall mean age: 58 years),
obese (overall mean body mass index (BMI): 31 kg/m2) and pre-hypertensive (overall mean
systolic blood pressure (SBP): 130 mmHg). Modest evidence of test statistic inflation was
noted for the family-based CFS (λ: 1.10) and JHS (λ: 1.08), although inflation was neither
observed in the remaining studies (λ range: 0.95, 1.04) nor in the overall meta-analysis after
genomic control was applied (λ: 1.008) (Supplemental Figure 1). A total of 2.8 million
genotyped and imputed autosomal SNPs were available for analysis after applying
genotyping and imputation quality control measures (Supplemental Table 1).
In the meta-analysis, 90 SNPs at six loci were associated with PR at the genome-wide
significance threshold of P < 5.0 × 10−8 after applying genomic control (Figure 1, Table 2).
The strongest primary PR signal (P = 5.26 × 10−43, primary signals defined as the locus-
specific SNP with the lowest P-value), was observed for rs3922844 in SCN5A (effect allele
frequency (AF) = 0.58), and corresponded to a 4.5 ms decrease in PR per copy of the C
allele (Figure 2c). We also identified two independent secondary signals at SCN5A/10A, a
region characterized by low patterns of linkage disequilibrium (LD) and multiple
recombination peaks (Figure 2C); one in SCN5A and a second in SCN10A, which was
located 14.3 kb downstream of the SCN5A primary signal (Table 2, secondary signals
defined as the locus-specific SNP with the lowest genome-wide significant P-value after
conditioning on primary signals and successive secondary signals). Estimates for the eight
signals (six primary; two secondary) were generally consistent across cohorts (Supplemental
Table 2), and there was little evidence of among-study heterogeneity (Cochran’s Q P ≥
0.05). The primary signals also were robust to adjustment for local ancestry (Supplemental
Table 3).
Five of the loci associated with PR were previously identified in populations of European
and Asian descent: SCN5A/SCN10A, MEIS1, ARHGAP24, CAV1, and TBX5. Of note,
SCN5A/SCN10A, MEIS1, and TBX5 were also reported by the earlier PR GWA study of
African Americans.12 The novel locus, ITGA9, was located on chromosome 3, greater than
one Mb upstream from the primary SCN5A signal. Several genes resided nearby ITGA9,
although only ITGA9 and C3orf35 harbored SNPs in strong to moderate LD with rs267567.
None of the primary or secondary signals reported here were the same as the index SNPs
reported in populations of European or Asian ancestry. Although we identified both a
primary and secondary SCN5A signal for PR, only one study of European ancestral
populations identified SCN5A,10 and this study reported an index SNP (rs11708996) that
was monomorphic in HapMap YRI. The SCN10A SNP that we identified (rs6801957) was
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in low LD with both previously identified SCN10A variants (rs6800541 and rs6795970 (r2 <
0.10, HapMap YRI)), which were reported in European ancestral populations. The MEIS1
index SNP rs3891585 was in moderate LD with the previously described variant
rs11897119 (r2 = 0.62, HapMap YRI). Of the two index SNPs reported for ARHGAP24 in
populations of European descent, rs7692808 was in high LD (r2 = 0.94, HapMap YRI) and
rs7660702 was in low LD (r2 = 0.22, HapMap YRI) with our ARHGAP24 primary signal.
Both studies that previously identified CAV1 as a PR-associated locus reported the
rs3807989 variant; this SNP was in very high LD with the primary CAV1 SNP presented
herein (r2 = 1.0, HapMap YRI). Finally, both GWA studies of PR that identified TBX5
reported the variant rs1895582, which also was in high LD with our TBX5 primary signal,
rs1895585 (r2 = 0.84, HapMap YRI).
We identified six loci associated with PR in populations of African descent, yet we were
unable to confirm associations at genome-wide significance thresholds for three PR loci that
were previously identified in individuals of European descent: NKX2–5, WNT11, and
SOX5.8 Although the previously reported chromosome 5 and 11 loci had high minor allele
frequencies (MAF) across contributing studies, consistent directions of effect, and little
evidence of heterogeneity, neither previously reported index SNP was associated with PR (P
> 0.01) (Table 3). Of note, all SNPs residing within a 1 Mb region of these loci had P-values
that exceeded 0.0009 (results not shown). Data for the previously reported SOX5 index SNP
were only available in six contributing studies and the mean estimated MAF was 0.03. The
SOX5 locus also was monomorphic in the HapMap YRI population and all P-values within
1 Mb of this locus exceeded 0.0002 (results not shown).
Discussion
This GWA study and meta-analysis of ten cohorts represents the largest effort in populations
of African descent to identify genetic determinants of PR. By building on recent work from
the CARe consortium,12 we identify three additional loci associated with PR in African
ancestral populations; ARHGAP24, CAV1, and ITGA9. The ITGA9 locus represents a
novel finding, having not been identified in any prior GWA studies of PR to date.
ITGA9 is located approximately 1.1 Mb upstream from SCN5A and encodes an alpha
integrin, an integral membrane glycoprotein that mediates diverse functions including cell–
cell and cell–matrix adhesion, proliferation, and apoptosis.17, 18 ITGA9 also has been
associated with hypertension19 and several cancers.20–22 Although, ITGA9 has not been
previously implicated in atrioventricular conduction, the extended 3p22–24 region has been
shown to harbor variants affecting SCN5A expression. It is therefore possible that ITGA9
marks a distal SCN5A regulatory element.23, 24 Interestingly, pathway analysis suggests a
role for ITGA9 in cation binding, hypertrophic cardiomyopathy, and dilated
cardiomyopathy.25 Expression QTL studies also have associated variation in ITGA9 with cis
expression data from monocytes26 and lymphoblastoid cell lines.27 However, the
transferability of associations to cardiac myocyte and conduction tissue warrants further
investigation.
In addition to identifying ITGA9 as a potential cis-regulator of SCN5A, we also reported
three independent SNPs influencing PR at the 3p21 locus. The 3p21 locus harbors both
SCN5A and SCN10A, which encode integral membrane proteins and tetrodotoxin-resistant
voltage-gated sodium channel subunits. The NAv1.5 sodium channel alpha-subunit (encoded
by SCN5A) is the predominant alpha-subunit expressed in cardiac muscle, and is
responsible for the initial upstroke of the action potential in an ECG.28 SCN5A mutations
are associated with Brugada syndrome, long-QT syndrome, dilated cardiomyopathy, cardiac
conduction disease, idiopathic ventricular fibrillation and atrial fibrillation28 and have been
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identified in GWA studies of the QT29, 30 and QRS intervals31 in populations of European
descent.
The NAv1.8 sodium channel alpha-subunit (encoded by SCN10A) is characterized by a
long-duration action potential and preservation of excitability during rapid and sustained
stimulation.32 Seven variants at 3p21 have been previously reported,8, 10, 12 and by
extending the work of Smith et al.,12 we detected an additional independent signal at
genome-wide significance levels. The presence of numerous independent signals at the 3p21
region in African Americans was previously reported by a SCN5A candidate gene study in
approximately 3,000 JHS participants, who also contributed to this analysis.33 By including
nine additional studies, we validate the previous work by Jeff and colleagues at genome-
wide significance levels and identify a neighboring genome-wide significant signal in
SCN10A. The ability to identify multiple SCN5A/SCN10A signals may in part be
attributable to the greater nucleotide diversity and lower LD in African populations, as 3p21
is characterized by low LD and high recombination.
In addition to SCN5A, we generalized four additional PR loci to populations of African
ancestry: ARHGAP24, MEIS1, TBX5, and CAV1, the latter of which was also detected by a
GWA study of atrial fibrillation.34 Yet, the importance of NKX2–5, WNT11, and SOX5 in
the genetic architecture of PR in African Americans is less clear. Although the “winner’s
curse” and inflated genetic effect estimates from initial discovery35 may help explain the
inconsistent results, another possibility is that our study was underpowered to detect these
loci, especially for the SOX5 locus. In addition, our analysis was conducted in populations
that were predominantly female, obese and pre-hypertensive. The degree to which these
characteristics influenced the results presented herein remains unclear.
Several limitations of the present study warrant further consideration in order to inform
future efforts examining the genetic architecture of PR. The first is study heterogeneity, a
common limitation of meta-analyses. In our meta-analysis, studies used common
measurement protocols for determining PR and its clinical correlates. In addition, statistical
assessments of heterogeneity did not suggest large variation in SNP effects across studies.
Another limitation is confounding, either from cryptic population stratification or
unmeasured PR risk factors. For example, one potential confounder we were unable to
consider was atrial size, given widespread unavailability of echocardiographs. However, we
adjusted for BMI, height, and systolic blood pressure, the major contributors to left atrial
size. Regarding the potential for bias from population substructure, we adjusted for principal
components in study-specific regression models and applied genomic control. These
approaches are standard in GWA studies, yet the potential for residual confounding to
produce either false-negative or false-positive results remains challenging to determine on a
genome-wide level. Finally, we were unable to independently replicate the association with
ITGA9 in an independent population given difficulties identifying additional studies of
African American participants with ECG measures, extant genotype data, and overlapping
analytical timelines. Although results from other ancestral population could provide
confirmatory evidence of the association between PR and ITGA9, failure to replicate could
simply reflect allelic heterogeneity.
In summary, our results suggest that polymorphisms from six loci on five chromosomes are
associated with PR in African Americans, including a novel signal in ITGA9 that may
function as a distal SCN5A regulatory element. Our expanded meta-analysis also
demonstrates the ability to map novel genes in African Americans and the generalizability of
genetic variants associated with PR across global populations. Future work to refine these
signals is clearly warranted, including additional examination of the extended chromosome
3p region that harbors SCN5A, SCN10A and ITGA9. GWA studies in other admixed
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populations, as well as fine-mapping efforts, would be especially useful for further




A meta-analysis of ten studies was performed to investigate the genetic determinants of PR.
Three cohorts were from COGENT including the Health, Aging, and Body Composition
Study (Health ABC n=1,054), the Healthy Aging in Neighborhoods of Diversity across the
Life Span Study (HANDLS, n=945), and the Women’s Health Initiative (WHI, n=4,149),
and four cohorts were available from the CARe consortium, including the ARIC study
(n=2,391), the CFS (n=267), the JHS (n=1,962), and MESA (n=1,627). The Baltimore
Longitudinal Study of Aging (BLSA, n=155), the Bogalusa Heart Study (BHS, n=191), and
the Cardiovascular Health Study (CHS, n=674) were the remaining contributing studies.
Additional information on the participating studies is provided in the Supplementary
Material. All studies were approved by local ethics committees and all participants provided
written informed consent.
PR interval measurement
For each study, certified technicians digitally recorded resting, supine (or semi-recumbent),
standard twelve-lead ECGs using comparable procedures for preparing participants, placing
electrodes, recording, transmitting, processing and controlling quality (Supplemental Table
4). Participants with the following characteristics were excluded: poor quality ECG, extreme
PR (320 ms≤ PR≤80 ms), documented history of atrial fibrillation/flutter, heart failure,
myocardial infarction, pacemakers antedating ECG assessment, Wolff-Parkinson-White
syndrome, and second/third degree heart block.
Genotype arrays and imputation
Genome-wide SNP genotyping was performed within each cohort using the Affymetrix or
Illumina genotyping arrays (Supplemental Table 1). First -degree relatives were excluded in
all studies except the family-based CFS and JHS. SNPs were excluded for genotyping call
rate thresholds between <95% and <99% and MAF ≤ 1%, the determination of which was
study-specific.
Imputation was performed for ~2.5 million autosomal SNPs based on a 1:1 ratio of the
HapMap Phase 2 CEU and YRI populations (Supplemental Table 1). SNPs with imputation
quality< 0.3 or inconsistent allele designations as per HapMap forward strands were
excluded. In addition, SNPs not seen in > 2 studies were excluded from the meta-analyses.
After exclusions, 2,845,108 genotyped and imputed SNPs were available.
Statistical analysis
Each study, with the exception of CFS, performed GWA analysis for PR across
approximately 2.5 million SNPs based on linear regression under an additive genetic model.
The family-based CFS study was analyzed using linear mixed-effects models as
implemented in the R GWAF package.36 Specifically, the within pedigree random genetic
effects were modeled using a kinship coefficient matrix, with each family having a different
covariance pattern. The full N × N kinship variance covariance matrix was generated using
the R kinship function within the GWAF software package, according to the algorithm of K.
Lange.37 Although the JHS has a limited number of related participants, extensive analyses
suggested that results from linear regression or linear mixed effects models were
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concordant.15 Therefore, JHS results are based on linear regression models unadjusted for
family structure.
The association of each SNP with PR was adjusted for age, sex, height, BMI, systolic blood
pressure, RR interval, and study site, when appropriate, to maintain consistency with Smith
et al.12 All studies included principal components in linear models to adjust for variation in
global ancestry (Supplemental Table 1).38 Genotyped data were substituted for imputed
data, when available. Individual study results were corrected by their respective genomic
inflation factors (λ);39 genomic inflation factors > 1 may indicate sample duplications,
unknown or poorly specified familial relationships, a poorly calibrated test statistic,
systematic technical bias, or gross population stratification.40
A fixed effects inverse variance meta-analysis was performed to combine beta coefficients
and standard errors from study-level regression results for each SNP. Primary signals were
defined as the locus-specific SNP with the lowest genome-wide significant P-value (P < 5 ×
10−8). Between-study heterogeneity of results was assessed by Cochran’s Q statistic. Meta-
analyses were implemented in the software METAL41 and were confirmed by an
independent analyst.
A two-stage strategy was used to identify secondary signals. First, LD pruning was
performed using PLINK, whereby independent signals were defined as at least two genome-
wide significant SNPs in low LD (r2 < 0.20) in the same 1 Mb region. Next, each study
performed a conditional analysis by adjusting for the most strongly associated SNP(s) at
each locus with at least two bins, restricting to SNPs with P-values < 5.0 × 10−8. SNPs
outside 1 Mb of the primary signal were not considered in conditional analyses because no
loci exhibited LD patterns that extended beyond 1 Mb, and because conditioning on
potential mediators may induce bias, the direction and magnitude of which are difficult to
predict.42 Results for secondary signals were presented after conditional adjustment that
adjusted for locus-specific primary signals. Additional iterations adjusting for subsequent
secondary signals as well as the primary signal were performed in the WHI, HABC,
HANDLS, and CHS cohorts (n=5,768, 43% of sample size) until no genome-wide
significant associations remained.
As a sensitivity analysis, we assessed the impact of local ancestry by including SNP-specific
local ancestry estimates as a covariate in models for genome-wide significant signals.
Locus-specific ancestry (i.e. probabilities of whether an individual has 0, 1, or 2 alleles of
African ancestry at each locus) was only available for directly genotyped SNPs and was
estimated using a Hidden Markov Model and the local haplotype structure to detect
transitions in ancestry along the genome.43
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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The PR interval (PR), a potent risk factor for arrhythmia, pacemaker implantation, heart
failure, stroke, and all-cause mortality, is influenced by many factors including common
and rare genetic variants.Recent genome-wide association (GWA) studies performed in
populations of European and Asian descenthave identified several common genetic
variants associated with PR, however, limited data exist on loci associated with PR in
African Americans. One exception is a PR GWA study by Smith et al. including6,247
participants from four cohorts. Here, we extend this meta-analysis by including an
additional 7,168participants fromsix cohorts in order to identify novel loci influencing
PR in African Americans. In addition to generalizing four PR loci in ARHGAP24,
MEIS1, TBX5, and CAV1 to populations of African ancestry, we identified one novel
signal in ITGA9 and two additional independent and genome-wide significant secondary
signals in the 3p21 region that harbors SCN5A and SCN10A. Our findings highlight the
ability to map novel loci in African Americans, the generalizability of loci associated
with PR across populations of African, European and Asian descent, and the new
mechanistic insights on biologic processes underlying PR.
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Manhattan plot of the association of SNPs with PR in a meta-analysis of ten African
American cohorts. The x-axis represents the chromosomal position for each SNP, and the y-
axis represents the −log10 P-value for association with PR, which is truncated at 1×10−23.
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Regional association plots of six loci associated with PR interval in ten African American
cohorts. SNP P-values (represented by circles) at each locus are shown on the −log10(P-
value) scale as a function of chromosomal position. Strength of LD is indicated by the color
category. Purple diamonds denotes the locus-specific primary signal. Recombination rate is
plotted in the background and known genes are shown on the bottom of the plot. A) MEIS1;
b) ITGA9; c) SCN5A; d) ARHGAP24; e) CAV1; f) TBX5.
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